Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Aurora Cannabis ( (TSE:ACB) ) has provided an announcement.
Aurora Cannabis, in collaboration with its subsidiary MedReleaf Australia, has removed the concession card requirement for its IndiMed products, allowing broader patient access to medical cannabis in Australia. This move reflects Aurora’s commitment to simplifying prescription processes and adapting quickly to market demands, enhancing its position in the growing Australian medical cannabis market.
More about Aurora Cannabis
Aurora Cannabis Inc. is a Canadian-based global leader in the medical cannabis industry, operating in nationally regulated markets. The company focuses on providing high-quality medical cannabis products and has a significant market presence through its various brands, including IndiMed.
YTD Price Performance: 47.11%
Average Trading Volume: 2,596,856
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $363.6M
Find detailed analytics on ACB stock on TipRanks’ Stock Analysis page.